An evidence based review of Dupilumab in the treatment of moderate to severe asthma

ConclusionConcomitant use of Dupilumab with ICS/LABA, improves clinical outcomes and quality of life in moderate to severe asthmatic patients. Though Dupilumab has a promising role in the asthma treatment, it is still in the emerging stage for its acceptance globally. Ongoing studies will help to determine Dupilumab's long-term efficacy and safety for its future extensive use.
Source: Current Therapeutic Research - Category: Drugs & Pharmacology Source Type: research